MedPath

Vitamin D Supplementation for the Prevention of Acute Respiratory Tract Infections

Not Applicable
Completed
Conditions
Respiratory Tract Infections
Interventions
Dietary Supplement: vitamin D
Dietary Supplement: placebo
Registration Number
NCT00973583
Lead Sponsor
Tampere University
Brief Summary

The investigators earlier clinical study in 754 young Finnish men demonstrated a significant negative association of serum 25-OHD concentration with acute respiratory tract infections. The present study aimed to determine whether vitamin D supplementation may decrease the incidence of acute respiratory tract infections.

Detailed Description

Subjects comprised 164 male conscripts at a military base in Finland. Half of the participants were randomly allocated to receive 400 IU vitamin D daily and half received placebo from October through March. Serum vitamin D and plasma parathyroid hormone concentrations were determined. Subjects were followed for 6 months and the primary outcome was the number of days absent from duty due to ARTI.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
164
Inclusion Criteria

Not provided

Read More
Exclusion Criteria
  • Use vitamin D
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
vitamin Dvitamin D-
placeboplacebo-
Primary Outcome Measures
NameTimeMethod
Number of days absent from duty due to respiratory tract infection6 months
Secondary Outcome Measures
NameTimeMethod
The proportion of men remaining healthy throughout the 6-month study period6 months
The number needed to treat calculated from the proportion of men without any days absent from duty6 months

Trial Locations

Locations (1)

university of Tampere

🇫🇮

Tampere, Finland

© Copyright 2025. All Rights Reserved by MedPath